Arylacetamide Deacetylase-Like 3 (AADACL3) Antibody

Background

Arylacetamide deacetylase like 3 (AADACL3) is a member of the serine hydrolase enzyme family involved in lipid metabolism, particularly in the hydrolysis of ester-containing lipids and other substrates. AADACL3 is thought to play a role in the remodeling of lipids within metabolic tissues, including the liver and adipose tissue, as well as in certain epithelial cells. Its activity has been associated with pathways that regulate lipid storage and mobilization, contributing to cellular energy balance and membrane lipid composition. Emerging evidence suggests that AADACL3 may also participate in signaling pathways involving bioactive lipid mediators, although its specific substrates and physiological functions remain under investigation. Dysregulation of AADACL3 expression or activity could potentially impact lipid homeostasis and contribute to metabolic disorders, highlighting its potential as a target for further research into lipid-related diseases.